Drug Discovery and Development for Schistosomiasis-Reference-Cited by-同舟云学术

Drug Discovery and Development for Schistosomiasis

Published:2019-08-02 Issue: Volume: Page:187-225
ISSN:1865-0562
Container-title:Neglected Tropical Diseases
language:
Short-container-title:

Author:

Caffrey Conor R.,El‐Sakkary Nelly,Mäder Patrick,Krieg Reimar,Becker Katja,Schlitzer Martin,Drewry David H.,Vennerstrom Jonathan L.,Grevelding Christoph G.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/9783527808656.ch8

Reference161 articles.

1. Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and schistosomal infection in mice

2. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

3. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

4. Human schistosomiasis

5. Schistosomiasis in Africa: An Emerging Tragedy in Our New Global Health Decade

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method for Synthesis of 4-(4-Hydroxyphenyl)cycloalkanedicarboxylic Acids Based on SEAr Alkylation;Журнал общей химии;2024-07-23

2. Pharmacophore Virtual Screening Identifies Riboflavin as an Inhibitor of the Schistosome Cathepsin B1 Protease with Antiparasitic Activity;ACS Omega;2024-05-30

3. Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis;ACS Infectious Diseases;2024-05-17

4. Human schistosomiasis in Nigeria: present status, diagnosis, chemotherapy, and herbal medicines;Parasitology Research;2023-10-18

5. In Vitro and In Vivo Antischistosomal Activity Profiling and Pharmacokinetics of Ozonide Carboxylic Acids;ACS Infectious Diseases;2023-02-16